Dying or Lying? For-Profit Hospices and End-of-Life Care

The Medicare hospice program is intended to provide palliative care to terminal patients, but patients with long stays in hospice are highly profitable, motivating concerns about overuse among the Alzheimer's and Dementia (ADRD) population in the rapidly growing for-profit sector. We provide the first causal estimates of the effect of for-profit hospice on patient spending using the entry of for-profit hospices over 20 years. We find hospice has saved money for Medicare by offsetting other expensive care among ADRD patients. As a result, policies limiting hospice use including revenue caps and antifraud lawsuits are distortionary and deter potentially cost-saving admissions. (JEL H51, I11, I12, I18, J14, L84)

Authors

Institutions

Publication Details

Journal
American Economic Review
Published
2024-12-30
DOI
https://doi.org/10.1257/aer.20230328
Citations
1
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
1.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dying or Lying? For-Profit Hospices and End-of-Life Care

Theodore L. Caputi, Jetson Leder‐Luis, David H. Howard, Jonathan Gruber
1 citations
American Economic Review
Health Systems, Economic Evaluations, Quality of Life
1.13
article

Dying or Lying? For-Profit Hospices and End-of-Life Care

Theodore L. Caputi, Jetson Leder‐Luis, David H. Howard, Jonathan Gruber
article en
1 citations

Abstract

The Medicare hospice program is intended to provide palliative care to terminal patients, but patients with long stays in hospice are highly profitable, motivating concerns about overuse among the Alzheimer's and Dementia (ADRD) population in the rapidly growing for-profit sector. We provide the first causal estimates of the effect of for-profit hospice on patient spending using the entry of for-profit hospices over 20 years. We find hospice has saved money for Medicare by offsetting other expensive care among ADRD patients. As a result, policies limiting hospice use including revenue caps and antifraud lawsuits are distortionary and deter potentially cost-saving admissions. (JEL H51, I11, I12, I18, J14, L84)

American Economic ReviewVol. 115(1)
Boston University (US), Emory University (US), Moscow Institute of Thermal Technology (RU)
Openalex Percentile: Top 10%
Health Systems, Economic Evaluations, Quality of Life
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.